Press releases & Media

Press releases

• A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA
  September 13, 2023
• Stockholm3 combines accurate diagnosis of prostate cancer with improved health economics
  August 31, 2023
• Stockholm3 included in the American Urological Association (AUA) guidelines for early detection of prostate cancer
  May 4, 2023

More press releases

A3P in media

• Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
  May 6, 2022
• Finally time for public screening of prostate cancer? (In Swedish)
  November 22, 2021
• Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
  October 6, 2021

More articles